Numbers of oocytes appear to not be affected in patients with CAH, as indicated by a study evaluating anti-mullerian hormone (AMH, a marker of ovarian reserve) that found no significant difference between CAH patients and controls and comparable levels between classic and NCCAH patients [32]. This evidence concerns the gene AMH and congenital adrenal hyperplasia.